With CannTrust still struggling to find their footing after last week’s debacle involving product produced in five unlicensed grow rooms being released to market, the situation continues to go from bad to worse. Approximately 5,200 kg of cannabis has since been placed on hold by Health Canada, over 14 class-action lawsuits have been filed by law firms representing claimants in both Canada and the United States, and fears of medical grade cannabis shortages plague patients relying on CannTrust produced product. All of this has culminated in an increasing distrust by both investors and the general public toward the truth and transparency being put forth by cannabis producers.
Where do we go from here?
To find out more on how this story is really shaking out, head on over to our straight-laced sister publication, Puff Puff Post, and read PPP Editor Connor Lovat-Fraser’s exclusive interview with TruTrace CEO Robert Galarza.